Form D · Other Technology
Koneksa Health Inc.
New York, NY · CIK 0001738351
Offering snapshot reported Apr 3, 2020 · SEC filing
- Reported sold
- $9.65M Offering amount: $15M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 25, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2020 | Initial | $9,649,990 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-364342
Source: Form D, filed Apr 3, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Benko | Director, Executive |
| Matthew Cantor | Director, Executive |
| Robert Ellis | Director, Executive |
| Robert Greenglass | Director |
| Steve Hirschfeld | Director |
| Elena Izmailova | Executive |
| Gol Ophir | Executive |
| Vikram Shah | Executive |
| Raymond L.M. Wong | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
199 Water Street, 34th Floor
New York, NY, 10038
New York, NY, 10038